Aduhelm, a new therapy from Biogen, is the first drug to target Alzheimer’s disease in nearly 20 years, and will have cascading effects on health care costs.Read More

Aduhelm, a new therapy from Biogen, is the first drug to target Alzheimer’s disease in nearly 20 years, and will have cascading effects on health care costs.Read More